Tag Archives: Needham

Cempra stock tanks on FDA concerns for lead drug’s side-effects; high hopes still riding on Friday AdCom meeting

Cempra Inc.’s (Chapel Hill NC) experimental drug to treat community-acquired pneumonia, the kind recently suffered by presidential candidate Hillary Clinton, causes a potentially concerning rise in liver enzymes, according to… Read more »

Wall Street Ponders Brexit’s Impact on Drug, Biotech Stocks

In a historic vote Thursday, Britain has decided to leave the European Union. And, swallowing hard, financial markets around the world are not taking the news very well. Stateside, the Dow… Read more »

Vericel Stem-Cell Therapy Reduces Deaths and Hospitalizations in Advanced Heart Failure Patients

VERICEL CORP.’s (Ann Arbor MI) stem-cell therapy helped reduce deaths and hospitalizations in advanced heart failure patients, according to data from a mid-stage study, potentially providing a treatment that could… Read more »